title: Ocriplasmin is a useful clinical tool; careful case selection will improve treatment results.
abstract: This editorial discusses the significance of the first reported case series of real-world use of ocriplasmin for treating symptomatic vitreomacular adhesion and addresses the importance of case selection in improving treatment results.
authors.forename: Carmen A
authors.initials: CA
authors.lastname: Puliafito
mesh_terms: D005260:Female; D005341:Fibrinolysin / Q000008:administration & dosage*; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D010446:Peptide Fragments / Q000008:administration & dosage*; D012164:Retinal Diseases / Q000188:drug therapy*
chemical_list: D005343:Fibrinolytic Agents; D010446:Peptide Fragments; C054561:microplasmin; D005341:Fibrinolysin